IL6 −174 G/C Promoter Polymorphism Influences Susceptibility to Mucosal but Not Localized Cutaneous Leishmaniasis in Brazil

BackgroundMucosal leishmaniasis (ML) is associated with exaggerated tumor necrosis factor–α and interferon-γ responses and tissue destruction. ML follows localized cutaneous leishmaniasis (CL) caused by Leishmania braziliensis infection. Interleukin (IL)–6 down-regulates T helper (Th) cell type 1 di...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 194; no. 4; pp. 519 - 527
Main Authors Castellucci, Léa, Menezes, Eliane, Oliveira, Joyce, Magalhães, Andrea, Guimarães, Luiz Henrique, Lessa, Marcus, Ribeiro, Silvana, Reale, Jeancarlo, Noronha, Elza Ferreira, Wilson, Mary E., Duggal, Priya, Beaty, Terri H., Jeronimo, Selma, Jamieson, Sarra E., Bales, Ashlee, Blackwell, Jenefer M., de Jesus, Amélia Ribeiro, Carvalho, Edgar M.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 15.08.2006
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundMucosal leishmaniasis (ML) is associated with exaggerated tumor necrosis factor–α and interferon-γ responses and tissue destruction. ML follows localized cutaneous leishmaniasis (CL) caused by Leishmania braziliensis infection. Interleukin (IL)–6 down-regulates T helper (Th) cell type 1 differentiation and drives Th2 cell differentiation. The IL6 −174 G/C polymorphism is associated with proinflammatory diseases and IL-6 regulation MethodsThe −174 G/C polymorphism was genotyped in population samples and families with CL and ML from Brazil. Genotype frequencies were compared among patients with ML, patients with CL, and 2 control groups by logistic regression and family-based association test (FBAT) analysis. IL-6 levels were measured in macrophages ResultsThe C allele was more common in patients with ML than in patients with CL (odds ratio [OR], 2.55 [95% confidence interval {CI}, 1.32–4.91]; P=.005), than in patients who were leishmanin skin-test positive (OR, 2.23 [95% CI, 1.23–4.05]; P=.009), and than in neighborhood control subjects (OR, 2.47 [95% CI, 1.24–4.90]; P=.01). FBAT analysis confirmed an association between allele C and ML under both additive (z=4.295; P=.000017) and dominant (z=4.325; P=.000015) models. Significantly lower levels of IL-6 were measured in unstimulated macrophages from CC individuals than from GG individuals (P=.003) as well as after stimulation with soluble leishmania antigen (P=.009) ConclusionsIL-6 may regulate type 1 proinflammatory responses, putting individuals with low macrophage IL-6 levels at increased risk for ML
Bibliography:istex:4FE3985F50B341436784716328CCF515B16556EC
ark:/67375/HXZ-1D0KVB2P-7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1086/505504